The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Berlin plans six vast COVID-19 vaccination centres handling 4,000 people a day

Thu, 26th Nov 2020 15:32

By Caroline Copley

BERLIN, Nov 26 (Reuters) - Berlin is racing to open six mass
vaccination centres capable of handling up to 4,000 people per
day by mid-December, the project coordinator told Reuters on
Thursday, as the city waits for authorities to approve the first
vaccines.

An empty trade fair hall, two airport terminals, a concert
arena, a velodrome and an ice rink will be turned into six
vaccination centres where it plans to administer up to 900,000
shots against the coronavirus in the first three months.

Albrecht Broemme said plans envisage 3,000 to 4,000 people
per day being ferried through each centre in the same way as
shoppers are guided through IKEA stores in one direction.

"The biggest challenge will be succeeding in getting the
right people at the right time at the right vaccination centre,"
Broemme said on the sidelines of a fire drill at the city's
makeshift COVID-19 hospital in a trade fair hall.

Germany appears to be the furthest ahead of European nations
in its planning for the daunting logistical and administrative
challenge that could be just a few weeks away if the first
vaccines gain approval.

Europe's drug watchdog expects to receive the first
application for conditional marketing approval for a COVID-19
vaccine "in the coming days", it said on Thursday, the latest
step towards making a shot available outside the United States.

Broemme said Berlin is working on the assumption that around
80% of its doses in the first instance will come from Pfizer
/BioNTech with the remaining 20% of the doses
from AstraZeneca.

Health Minister Jens Spahn said Germany has secured around
300 million vaccine doses. Other German states have said
vaccination centres will be ready from mid-December and mobile
teams will inoculate the most vulnerable.

Elsewhere in Europe, preparations appear mixed.

In Spain, the government aims to vaccinate a substantial
part of its population in the first half of 2021 and has opted
to use trucks rather than centres to distribute the shots.

Italy expects to have vaccinated most Italians by next
September and is due to set out detailed plans on Dec. 2. France
has said it could start administering shots as soon as the end
of the year and will unveil its strategy next week.

Britain plans to roll out vaccines using a mixture of
centres and doctors' practices and is aiming to have enough
shots to have some sort of normality after Easter.

In contrast, Hungary and Bulgaria are not expecting to
receive their first shipments until Spring.

Berlin's vaccination centres will be open seven days a week
and on public holidays from 0900 to 1900, Broemme said, with the
aim of completing the first phase within three months. After
that people will get shots at doctors' practices and pharmacies.

Those aged over 75 and healthcare workers are expected to be
first-in-line, the city's health senator said last week.

One challenge will be finding enough staff to operate the
centres, which will need medical professionals, stewards and
security guards. EasyJet has offered some of its
first-aid trained staff, a spokesman said.

Broemme expects each person to spend around one hour in the
centre. People will be monitored for side effects for around 30
minutes after receiving a shot amid strict social-distancing and
hygiene standards.
(Reporting by Caroline Copley
Additional reporting by Alistair Smout and Sarah Young in
London, Emilio Paradi in Milan, Emma Pinedo Gonzalez in Madrid,
Matthias Blamont in Paris, Krisztina Than in Budapest, Tsvetelia
Tsolova in Sofia)

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.